Antimicrobial Consumption in Latin American Countries: First Steps of a Long Road Ahead

• Autores: Marín, Gustavo Horacio; Giangreco, Lucía; Dorati, Cristian Matías; Mordujovich de Buschiazzo, Perla; Boni, Silvia; Mantilla Ponte, Hilda; Alfonso Arvez, María José; López Peña, Mónica; Aldunate González, María Francisca; Ching Fung, Shing Mi; Barcelona, Laura; Campaña, Laura; Vaquero Orellana, Alejandra; Orjuela Rodríguez, Tatiana; Ginés Cantero, Larissa; Villar, Rosa A.; Sandoval Fuentes, Nicole; Melero, Emiliano; Marin Piva, Hugo; Soler, Gisela; Gabriel, Fernanda; Pineda Velandia, Laura; Ojeda Florentín, Cinthia; Risso Patron, Soledad; Ortiz Rivas, Mariela; Mendoza Benítez, Carolina; Mellado, Rosemarie; Ivanovska, Verica; Muller, Arno; Rojas, Robin; Castro, José Luis
• Año de publicación: 2022
• Idioma: inglés
• Tipo de recurso: artículo
• Materia: Ciencias Médicas; antimicrobial; consumption; data source; information; GLASS; Latin America
• Institución: Universidad Nacional de La Plata

Background: Irrational antimicrobial consumption (AMC) became one of the main global health problems in recent decades. Objective: In order to understand AMC in Latin-American Region, we performed the present research in 6 countries. Methods: Antimicrobial consumption (J01, A07A, P01AB groups) was registered in Argentina, Chile, Colombia, Costa Rica, Paraguay, and Peru. Source of information, AMC type, DDD (Defined Daily Doses), DID (DDD/1000 inhabitants/day), population were variables explored. Data was analyzed using the Global Antimicrobial Resistance and Use Surveillance System (GLASS) tool. Results: Source of information included data from global, public, and private sectors. Total AMC was highly variable (range 1.91-36.26 DID). Penicillin was the most consumed group in all countries except in Paraguay, while macrolides and lincosamides were ranked second. In terms of type of AMC according to the WHO-AWaRe classification, it was found that for certain groups like “Reserve,” there are similarities among all countries. Conclusion and Relevance: This paper shows the progress that 6 Latin-American countries made toward AMC surveillance. The study provides a standardized approach for building a national surveillance system for AMC data analysis. These steps will contribute to the inclusion of Latin-America among the regions of the world that have periodic, regular, and quality data of AMC.
Facultad de Ciencias Médicas